Insulatard Innolet

Insulin Human, the active ingredient in Insulatard Innolet, is an insulin presented as an injectable solution for subcutaneous use. It treats type 1 and type 2 diabetes mellitus in adults and children as prescribed.

GNH USA supplies Insulatard Innolet as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Insulatard Innolet, a human insulin, is used to manage blood glucose in diabetes mellitus.

Type 1 diabetes mellitus: provides basal insulin to maintain fasting glucose levels. Type 2 diabetes mellitus: adds basal insulin to improve glycemic control when oral agents are insufficient.

Insulatard Innolet may cause a range of adverse reactions.

Common Side Effects: - Hypoglycemia (low blood sugar) - Injection site pain or redness - Weight gain - Peripheral edema

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Hypoglycemia unawareness leading to seizures - Development of insulin antibodies causing resistance

Use of Insulatard Innolet requires careful monitoring and patient education.

Monitor blood glucose regularly: adjust dose based on readings. Adjust dose during illness or stress: risk of hyperglycemia. Use with caution in renal or hepatic impairment: altered insulin clearance. Avoid in patients with known hypersensitivity to human insulin. Pregnancy category B: may be used if benefits outweigh risks. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Insulatard Innolet can interact with several drug classes.

Major Interactions (Avoid): - Concurrent use of other insulin preparations: increased risk of severe hypoglycemia. - Beta‑adrenergic blockers: may mask hypoglycemia symptoms.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic agents (e.g., sulfonylureas): additive glucose‑lowering effect. - ACE inhibitors: may potentiate insulin’s effect on glucose. - Thiazide diuretics: may reduce insulin sensitivity.